Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2155-2160

  Huang, Pingping ^a,b   Li, Shangzhu ^a   Han, Mingzhe ^a   Xiao, Zhijian ^a   Yang, Renchi ^a   Han, Zhong Chao ^a,b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b TEDA Center of Life Science and Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; AUTOTRANSPLANTATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; LIMB PAIN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; RANDOMIZED CONTROLLED TRIAL; SKIN ULCER;

AGED; DEBRIDEMENT; DIABETIC ANGIOPATHIES; DIABETIC FOOT; EXTREMITIES; FEMALE; FOOT ULCER; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; NECROSIS; NEUTROPHILS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 24144480964     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2155     Document Type: Article

References (28)

1. Kugler CF, Rudofskey G: The challenges of treating peripheral arterial disease. Vasc Med 8:109-114, 2003
2. Eckardt A, Kraus O, Kustner E, Neufang A, Schmiedt W, Meurer A, Schollner C, Schadmand-Fischer S: Interdisciplinary treatment of diabetic foot syndrome. Orthopade 32:190-198, 2003
3. Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld A-J: Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199, 2004
4. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786, 2002
5. Lechner A, Habener JF: Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab 284:E259-E266, 2003
6. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402, 2001
7. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, Kojima H, Iwasaka T: Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106:2019-2025, 2002
8. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106: 571-578, 2000
9. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial cells for neovascularization. Nat Med 5:434-438, 1999
10. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K: Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg 75: 204-209, 2003
11. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427-435, 2002
12. Yang C, Zhang ZH, Li ZJ, Yang RC, Qian GQ, Han ZC: Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost 91: 1202-1212, 2004
13. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T: Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 104:2057-2062, 2001
14. Fukumoto Y, Miyamoto T, Okamura T, Gondo H, Iwasaki H, Horiuchi T, Yoshizawa S, Inaba S, Harada M, Niho Y: Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol 97:666-668, 1997
15. Kawachi Y, Watanabe A, Uchida T, Yoshizawa K, Kurooka N, Setsu K: Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor. Br J Haematol 94:413-416, 1996
16. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJM: A comparison of two diabetic foot ulcer classification systems. Diabetes Care 24:84-88, 2001
17. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC: CD344-blood cells accelerate neovascularization and healing of diabetic mouse skin wounds. J Vasc Res 40:368-377, 2003
18. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S: Endothelial progenitor cells: new hope for a broken heart. Circulation 107:3093-3100, 2003
19. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77, 2000
20. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 95:952-958, 2000
21. Gordon PR, Leimig T, Babarin-Dorner A, Houston J, Holladay M, Mueller I, Geiger T, Handgretinger R: Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells Bone Marrow Transplant 31:17-22, 2003
22. Huang PP, Li SZ, Ran MZ, Xiao ZJ, Yang RC, Han ZC: Autologous transplantation of peripheral blood stem cells as treatment for arteriosclerosis obliterans of lower extremities. Thromb Haemost, 91: 606-609, 2004
23. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, Eberli FR, Meier B: Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104:2012-2017, 2001
24. Minamino K, Adachi Y, Okigaki M, Ito H, Togawa Y, Fujita K, Tomita M, Suzuki Y, Zhang Y, Iwasaki M, Nakano K, Koike Y, Matsubara H, Iwasaka T, Matsumura M, Ikehara S: Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells 23: 347-354, 2005
25. Wang Y, Tagil K, Ripa RS, Nilsson JC, Carstensen S, Jorgensen E, Sondergaard L, Hesse B, Johnsen HE, Kastrup J: Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular per-fusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 100:477-483, 2005
26. de Lalla F, Pellizzer G, Strazzabosco M, Martini Z, Du Jardin G, Lora L, Fabris P, Benedetti P, Erle G: Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 45:1094-1098, 2001
27. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA: Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury. Diabetes 53:91-98, 2004
28. Peshavaria M, Pang K: Manipulation of pancreatic stem cells for cell replacement therapy. Diabetes Technol Ther 2:453-460, 2000